LAMIRA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 16 Nov 2024)
What this means for you
Registered since 25 Dec 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Dec 2028: the §8 & §9 renewal).
Record
- Serial number
- 86619954
- Registration number
- 5638220
- Mark type
- Word mark
- Filed
- 05 May 2015
- Published for opposition
- 13 Oct 2015
- Registered
- 25 Dec 2018
- Next maintenance filing
- §8 & §9 renewal, due by 25 Dec 2028 (grace period to 25 Jun 2029)
- Attorney of record
- Robin C. Vance
Goods and services
- Class 010 — Medical apparatus: Medical devices for application of substances into the lungs, namely, nebulizers, inhalers, compressors used in the treatment of respiratory diseases
Owner
- PARI Pharma GmbH, Starnberg, DE
- PARI Pharma GmbH, Starnberg, DE
- PARI Pharma GmbH, Starnberg, DE
Board proceedings on this mark
- Opposition No. 91226211 — Laverana GmbH & Co. KG v. PARI Pharma GmbH, filed 08 Feb 2016 (Terminated)
- Extension of Time to Oppose No. 86619954 — Laverana GmbH & Co. KG v. PARI Pharma GmbH, filed 10 Nov 2015 (Terminated)
Prosecution history
- 15 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Jul 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 15 Jul 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 Nov 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 16 Nov 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 16 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
- 25 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 25 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 17 Nov 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Nov 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Nov 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Nov 2018 — STATEMENT OF USE PROCESSING COMPLETE